Related Experiment Video
Updated: Mar 19, 2026

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method
Published on: August 2, 2021
Incentive Sensitivity as a Behavioral Marker of Clinical Remission From Major Depressive Episode
Thomas Mauras1,2,3, Marc Masson4, Philippe Fossati2
1Brain & Spine Institute, MBB Team, 47, Bd de l'hôpital 75651 Paris Cedex 13, Paris 75013 France. thomasmauras@gmail.com.
Background:
Reduction of goal-directed behaviors is frequently observed in depression and may be linked to dysfunction of incentive motivation process.
Objective:
To investigate whether incentive sensitivity could constitute a behavioral marker of clinical remission in major depression.
Methods:
A handgrip force measurement device was employed to assess the impact of incentive motivation and emotional manipulation on the effort produced by remitted patients (n = 20) compared to matched depressed patients (n = 22) and healthy controls (n = 26). Depressed and remitted patients fulfilled the major depressive disorder DSM-IV criteria for current episode and remission state, respectively. The study was performed between March and July 2013.
Results:
Relative to patients with acute depression, patients after remission retrieved a normal sensitivity to incentives (t1,40 = 4.18, P < 1.5 × 10-4), but relative to healthy controls, they kept an abnormally high susceptibility to emotional arousal (t1,44 = 2.4, P = .02). Normalization of incentive sensitivity exhibited in the behavioral test was associated with improvement of apathy measured on the clinical scale.
Conclusions:
Using a simple behavioral paradigm at patients' bedside, we could identify the factors influencing effort production, so as to discriminate remitted patients from both depressed patients and healthy controls.
Related Concept Videos
Depressive Disorders: MDD and Dysthymia
Antidepressant Drugs: MAOIs and Other Agents
Depressive Disorders: Etiology
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...

